Research Solutions, Inc. (NASDAQ:RSSS) Short Interest Update

Research Solutions, Inc. (NASDAQ:RSSS - Get Free Report) experienced a notable rise in short interest in December. As of December 15th, short interest totaled 41,400 shares, marking a significant increase of 56.2% compared to the November 30th figure of 26,500 shares. With an average daily trading volume of 119,200 shares, the current days-to-cover ratio stands at 0.3 days.

Institutional Investors Weigh In On Research Solutions

Several institutional investors and hedge funds have recently adjusted their positions in Research Solutions. Oppenheimer Asset Management Inc. boosted its stake in the company by 36.5% during the second quarter, now holding 136,932 shares worth $349,000 after acquiring an additional 36,599 shares during the period. Renaissance Technologies LLC also increased its holdings by 12.6%, owning 117,100 shares valued at $299,000 after purchasing 13,089 shares additionally in the same quarter. Moreover, Luxor Capital Group LP established a new stake in Research Solutions amounting to approximately $411,000 in the second quarter. Dynamic Advisor Solutions LLC augmented its stake by 8.7% in the third quarter, now having 187,122 shares valued at $511,000 after acquiring an extra 14,950 shares. Lastly, Bard Associates Inc. grew its stake by 1.4% in the third quarter, currently holding 626,725 shares valued at $1,711,000 after buying an additional 8,455 shares. In total, institutional investors and hedge funds own 33.60% of the company's shares.

Research Solutions Price Performance

The stock opened at $4.14 on Friday. Research Solutions has a fifty-day simple moving average of $3.27 and a 200-day simple moving average of $2.88. The company’s shares have varied within the year, with a low of $2.38 and a high of $4.19. Research Solutions holds a market capitalization of $134.60 million, a PE ratio of -51.75, a price-to-earnings-growth ratio of 4.42, and a beta of 0.60.

About Research Solutions

Research Solutions, Inc, through its subsidiaries, offers a cloud-based software-as-a-service platform along with related services for corporate, academic, government, and individual researchers across the United States, Europe, and internationally. The company’s Discover platform aids in navigating scientific, technical, and medical (STM) articles, providing basic search solutions and advanced tools, including Resolute.ai and scite.ai, which helps in identifying relevant research and insights from various datasets related to STM content, including clinical trials, patents, and regulatory information.

stocks, investors, performance